146 related articles for article (PubMed ID: 24183863)
1. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer.
Thörnqvist S; Hysing LB; Zolnay AG; Söhn M; Hoogeman MS; Muren LP; Bentzen L; Heijmen BJ
Radiother Oncol; 2013 Dec; 109(3):344-9. PubMed ID: 24183863
[TBL] [Abstract][Full Text] [Related]
2. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
[TBL] [Abstract][Full Text] [Related]
3. Adaptive radiotherapy in locally advanced prostate cancer using a statistical deformable motion model.
Thörnqvist S; Hysing LB; Zolnay AG; Söhn M; Hoogeman MS; Muren LP; Heijmen BJ
Acta Oncol; 2013 Oct; 52(7):1423-9. PubMed ID: 23964658
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
[TBL] [Abstract][Full Text] [Related]
5. What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques.
Meijer GJ; de Klerk J; Bzdusek K; van den Berg HA; Janssen R; Kaus MR; Rodrigus P; van der Toorn PP
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1416-25. PubMed ID: 18439767
[TBL] [Abstract][Full Text] [Related]
6. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration.
Thörnqvist S; Petersen JB; Høyer M; Bentzen LN; Muren LP
Acta Oncol; 2010 Oct; 49(7):1023-32. PubMed ID: 20831491
[TBL] [Abstract][Full Text] [Related]
7. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
[TBL] [Abstract][Full Text] [Related]
8. Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins.
Kershaw L; van Zadelhoff L; Heemsbergen W; Pos F; van Herk M
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):68-77. PubMed ID: 29051038
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
[TBL] [Abstract][Full Text] [Related]
10. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.
Thörnqvist S; Bentzen L; Petersen JB; Hysing LB; Muren LP
Acta Oncol; 2011 Aug; 50(6):926-34. PubMed ID: 21767193
[TBL] [Abstract][Full Text] [Related]
11. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
[TBL] [Abstract][Full Text] [Related]
12. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.
Zelefsky MJ; Crean D; Mageras GS; Lyass O; Happersett L; Ling CC; Leibel SA; Fuks Z; Bull S; Kooy HM; van Herk M; Kutcher GJ
Radiother Oncol; 1999 Feb; 50(2):225-34. PubMed ID: 10368047
[TBL] [Abstract][Full Text] [Related]
13. [Quantification of the volumetric benefit of image-guided radiotherapy (IGRT) in prostate cancer: margins and presence probability map].
Cazoulat G; de Crevoisier R; Simon A; Louvel G; Manens JP; Lafond C; Haigron P
Cancer Radiother; 2009 Sep; 13(5):365-74. PubMed ID: 19643650
[TBL] [Abstract][Full Text] [Related]
14. [Patient positioning using in-room kV CT for image-guided radiotherapy (IGRT) of prostate cancer].
Kliton J; Agoston P; Major T; Polgár C
Magy Onkol; 2012 Sep; 56(3):193-8. PubMed ID: 23008828
[TBL] [Abstract][Full Text] [Related]
15. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
Mutanga TF; de Boer HC; van der Wielen GJ; Hoogeman MS; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1160-7. PubMed ID: 21035957
[TBL] [Abstract][Full Text] [Related]
16. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer.
Liang J; Wu Q; Yan D
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):935-43. PubMed ID: 19111401
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
Sheng Y; Li T; Lee WR; Yin FF; Wu QJ
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):473-480. PubMed ID: 28463167
[TBL] [Abstract][Full Text] [Related]
18. A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.
Lyons CA; King RB; Osman SOS; McMahon SJ; O'Sullivan JM; Hounsell AR; Jain S; McGarry CK
Radiat Oncol; 2017 Aug; 12(1):124. PubMed ID: 28778178
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
20. Impact of prostate focused alignment on planned pelvic lymph node dose.
Kilian-Meneghin J; Ma T; Kumaraswamy L
J Appl Clin Med Phys; 2021 Jul; 22(7):27-35. PubMed ID: 34231945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
